Literature DB >> 1971443

Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis.

S E File1.   

Abstract

Changes in hormones of the hypothalamic-pituitary-adrenal (HPA) axis in patients suffering from anxiety and depressive disorders are reviewed, and the changes that occur when animals are exposed to test situations used preclinically to model anxiety or depression. The effects of exogenous administration of HPA hormones both clinically and in animal tests is discussed and the effects of clinically used anxiolytics and antidepressants on hormones of the HPA axis. The final section discusses stress-induced changes in the CNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971443     DOI: 10.1016/0163-7258(90)90024-v

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  5 in total

1.  Sex differences in conflict behaviour and in plasma corticosterone levels.

Authors:  D Pericić; N Pivac
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer.

Authors:  Aliza Z Weinrib; Sandra E Sephton; Koen Degeest; Frank Penedo; David Bender; Bridget Zimmerman; Clemens Kirschbaum; Anil K Sood; David M Lubaroff; Susan K Lutgendorf
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

3.  5-HT1A receptor-effector system responsivity in panic disorder.

Authors:  K P Lesch; M Wiesmann; A Hoh; T Müller; J Disselkamp-Tietze; M Osterheider; H M Schulte
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze.

Authors:  T H Privette; D M Terrian
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

5.  Corticosterone increases severity of acute withdrawal from ethanol, pentobarbital, and diazepam in mice.

Authors:  A J Roberts; J C Crabbe; L D Keith
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.